| Literature DB >> 27452627 |
Apurva Atak1, Shuvolina Mukherjee1, Rekha Jain1, Shabarni Gupta1, Vedita Anand Singh1, Nikita Gahoi1, Manubhai K P1, Sanjeeva Srivastava2.
Abstract
The discovery of DNA microarrays was a major milestone in genomics; however, it could not adequately predict the structure or dynamics of underlying protein entities, which are the ultimate effector molecules in a cell. Protein microarrays allow simultaneous study of thousands of proteins/peptides, and various advancements in array technologies have made this platform suitable for several diagnostic and functional studies. Antibody arrays enable researchers to quantify the abundance of target proteins in biological fluids and assess PTMs by using the antibodies. Protein microarrays have been used to assess protein-protein interactions, protein-ligand interactions, and autoantibody profiling in various disease conditions. Here, we summarize different microarray platforms with focus on its biological and clinical applications in autoantibody profiling and PTM studies. We also enumerate the potential of tissue microarrays to validate findings from protein arrays as well as other approaches, highlighting their significance in proteomics.Entities:
Keywords: Autoantibody profiling; PTM studies; Protein arrays; Tissue microarrays
Mesh:
Substances:
Year: 2016 PMID: 27452627 DOI: 10.1002/pmic.201600104
Source DB: PubMed Journal: Proteomics ISSN: 1615-9853 Impact factor: 3.984